Notably, one of the genes targeted by this shRNA construct is Babam1, which is known to increase the metastatic capability of a murine Kras-mutant lung cancer-derived cell line (Chen et al., 2015), (Supplementary file 1). The gene discussed is BABAM1; the disease is lung carcinoma.